Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
26.45
-1.18 (-4.27%)
Jul 31, 2026, 10:38 AM EDT - Market open
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
$141,844
Profits / Employee
-$869,092
Market Cap
1.46B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Recursion Pharmaceuticals | 600 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Xencor | 260 |
| Zymeworks | 243 |
| Innoviva | 159 |
| Septerna | 130 |
MAZE News
- 7 weeks ago - Maze Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Maze Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Maze Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Maze Therapeutics Slides: Investor presentation - Filings
- 2 months ago - Maze Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Maze Therapeutics reports Q1 EPS (45c), consensus (63c) - TheFly
- 2 months ago - Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 2 months ago - Maze Therapeutics Earnings release: Q1 2026 - Filings